Imaging business PME has been a strong performer post COVID with its strong half-year result delivered in March confirming the business is kicking goals – revenue was up almost 8% to $31.6m while profit was just shy of $20m. We think PME is very likely to test $50 over the next 12-months but the risk / reward is only compelling under $40.
scroll
Question asked
Question asked
Question asked
Question asked
Gerrish: The correction is done, we’re positioning for what comes next
Close
A discussion with Geoff Wilson – Wilson Asset Management & James Gerrish – Market Matters
Close
Friday 9th May – Dow up +254pts, SPI up +3pts
Close
MM likes PME under $40
Add To Hit List
Related Q&A
Turnaround Opportunities
Xero (XRO), Wisetech (WTC), Pro Medicus (PME), and ANZ Bank (ANZ)
PME results / portfolio weightings
Does MM like Pro Medicus (PME) at current levels?
Relevant suggested news and content from the site

Video
WATCH
Gerrish: The correction is done, we’re positioning for what comes next
The Market Matters lead portfolio manager talks the recent recovery, Trump, gold, and why he thinks there's plenty of opportunities.

Video
WATCH
A discussion with Geoff Wilson – Wilson Asset Management & James Gerrish – Market Matters
Recorded Monday 31st March

Podcast
LISTEN
Friday 9th May – Dow up +254pts, SPI up +3pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.